Article
With biopharma IPOs surging, GoodRx guns for $750M raise
Rating:
0.0
Views:
116
Likes:
1
Library:
1
The 2020 biopharma IPO wave has picked up a company or two that doesn't look like your traditional drug developer. In June, most notably, Royalty Pharma, a company that has made a tidy business over the years buying up future royalties for approved and experimental drugs, nabbed the largest biotech
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value